| Bode M
[Comment on the Cochrane analysis >>Dopamine agonist therapy in early Parkinson's disease<<] [JOURNAL ARTICLE]
Ugeskr Laeger 2009 Oct 5; 171(41):2996-2999.
Abstract | Full Citation | Find Related Articles | | Maertens de Noordhout A
[Management of Parkinson's disease in 2009] [English Abstract, Journal Article]
Rev Med Suisse 2009 Aug 26; 5(214):1650-5.
Abstract | Full Citation | | Lukhanina EP, Kapustina MT, Berezetskaya NM, et al.
Reduction of the postexcitatory cortical inhibition upon paired-click auditory stimulation in patients with Parkinson's disease. [JOURNAL ARTICLE]
Clin Neurophysiol 2009 Sep 18.
Abstract | Full Citation | | Shin JY, Park HJ, Ahn YH, et al.
Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: A direct comparison study. [JOURNAL ARTICLE]
J Neurochem 2009 Sep 16.
Abstract | Full Citation | | Singla R, Singla A, Kumar S, et al.
Neuroleptic malignant syndrome without withdrawal of levodopa. [Letter]
Natl Med J India 2009 May-Jun; 22(3):162.
Full Citation | | Acler M, Fiaschi A, Manganotti P
Long-term levodopa admnistration in chronic stroke patients. A clinical and neurophysiologic single-blind placebo-controlled cross-over pilot study. [Journal Article]
Restor Neurol Neurosci 2009; 27(4):277-83.
Abstract | Full Citation | Find Related Articles | | Khan W, Naz S, Rana AQ
Shortness of breath, a 'wearing-off' symptom in Parkinson's disease. [Journal Article]
Clin Drug Investig 2009; 29(10):689-91.
Abstract | Full Citation | Find Related Articles | | Marin C, Aguilar E, Mengod G, et al.
Effects of early vs. late initiation of levodopa treatment in hemiparkinsonian rats. [Journal Article, Research Support, Non-U.S. Gov't]
Eur J Neurosci 2009 Sep; 30(5):823-32.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Porta F, Mussa A, Concolino D, et al.
Dopamine agonists in 6-pyruvoyl tetrahydropterin synthase deficiency. [Comparative Study, Journal Article]
Neurology 2009 Aug 25; 73(8):633-7.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Hondebrink L, Meulenbelt J, Timmerman JG, et al.
Amphetamine reduces vesicular dopamine content in PC12 and chromaffin cells only following l-DOPA exposure. [JOURNAL ARTICLE]
J Neurochem 2009 Aug 22.
Abstract | Full Citation | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
